SYNOPSIS Twelve patients presenting to an emergency department in headache crisis were treated with Ketorolac tromethamine 60 mg. intramuscularly. All improved sufficiently to require no further emergent treatment. There was statistically significant improvement on all segments of the short form McGill Pain Questionnaire. This open label trial suggests that Ketorolac Tromethamine may be a useful agent in the treatment of heed‐ache crisis, and a controlled study to examine this is warranted.
|Original language||English (US)|
|Number of pages||2|
|Journal||Headache: The Journal of Head and Face Pain|
|State||Published - Jul 1991|
ASJC Scopus subject areas
- Clinical Neurology